Sage Journals: Discover world-class research

Open access

Research article

First published 2022-3

Relationship of concomitant anti-diabetic drug administration with sodium-glucose co-transporter 2 inhibitor-related ketosis

Cheng-Wei Lin, Shih-Yuan Hung, I-Wen Chen

Journal of International Medical Research

Free access

Brief report

First published 2018-3

Impacts of sodium-glucose co-transporter type 2 inhibitors on central blood pressure

Tsuneo Takenaka, Yoichi Ohno, Hiromichi Suzuki

Diabetes & Vascular Disease Research

Open access

Case report

First published 2016-9

Sodium glucose co-transporter 2 inhibitors in patients with resistant hypertension: a case study

Amira Obeid, Mark Pucci, Una Martin [...]

JRSM Open

Free access

Brief report

First published 2017-5

Sodium–glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy

Tsuneo Takenaka, Miyako Kishimoto, Mari Ohta [...]

Diabetes & Vascular Disease Research

Free access

Review article

First published 2021-7

Sodium-glucose co-transporter 2 inhibitors: game changers when handled with care?

Zay M Htet, Mahzuz Karim

Journal of the Royal Society of Medicine

Open access

Review article

First published 2025

Direct Cardiac Mechanisms of the Sodium Glucose Co-Transporter 2 Inhibitor Class

Steven Hopkins, Faiz Baqai, Saivaroon Gajagowni [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Research article

First published 2015-09

The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors

Arthur L. M. Swislocki, Ishwarlal Jialal

Metabolic Syndrome and Related Disorders

Retricted access

Research article

First published 2022-05-17

Association Between Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Cognitive Function in a Longitudinal Study of Patients with Type 2 Diabetes

Serena Low, Kiat Sern Goh, Tze Pin Ng [...]

Journal of Alzheimer’s Disease

Open access

Review article

First published 2023-3

The rationale for the need to study sodium-glucose co-transport 2 inhibitor usage in peritoneal dialysis patients

Megan Borkum, Abeed Jamal, Rajinder Suneet Singh [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Open access

Review article

First published 2016-6

Benefits/Risks of Sodium–Glucose Co-Transporter 2 Inhibitor Canagliflozin in Women for the Treatment of Type 2 Diabetes

Pamela Kushner

Women's Health

Search results